Hematological Malignancies

HD7 trial For early favorable HL (FFTF) )

0.0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0

8-year estimate

95%-CI

FFTF

ArmA, EFRT

65.8%

[59.5% - 72.0%] [81.7% - 90.7%] [12.7% - 28.1%]

Arm B, ABVD+EFRT 86.2%

Arm difference

20.4%

RT

CT+RT

0

12

24

36

48

60

72

84

96 108 120

Time [months]

Pts. at Risk

RT

311 316

282 255 232 206 170 131 99 291 287 274 251 219 166 132 85 68

36 49

16 26

CT+RT

Engert et al, JCO 2007